Literature DB >> 34107549

The reduced form of the antibody CH2 domain.

Zhaoyong Xi1, Xianglei Liu2, Rui Lin1,3, John D Persons1, Tatiana V Ilina1, Wei Li2, Dimiter S Dimitrov2, Rieko Ishima1.   

Abstract

Among the immunoglobulin domains, the CH2 domain has the lowest thermal stability, which also depends on amino acid sequence and buffer conditions. To further identify factors that influence CH2 folding and stability, we characterized the domain in the reduced form using differential scanning fluorimetry and nuclear magnetic resonance. We show that the CH2 domain can fold, similarly to the disulfide-bridged form, without forming a disulfide-bridge, even though the protein contains two Cys residues. Although the reduced form exhibits thermal stability more than 15°C lower than the disulfide-bridged form, it does not undergo immediate full oxidization. To explain this phenomenon, we compared CH2 oxidization at different conditions and demonstrate a need for significant fluctuation of the folded conformation to enhance CH2 disulfide-bridge formation. We conclude that, since CH2 can be purified as a folded, semi-stable, reduced protein that can coexist with the oxidized form, verification of the level of oxidization at each step is critical in CH2 engineering studies.
© 2021 The Protein Society.

Entities:  

Keywords:  CH2; NMR; antibody; disulfide-bridge; thermal denaturation

Mesh:

Substances:

Year:  2021        PMID: 34107549      PMCID: PMC8376410          DOI: 10.1002/pro.4142

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.993


  73 in total

1.  Alternative binding proteins get mature: rivalling antibodies.

Authors:  Harald Kolmar; Arne Skerra
Journal:  FEBS J       Date:  2008-04-24       Impact factor: 5.542

Review 2.  Non-immunoglobulin based protein scaffolds.

Authors:  John Löfblom; Fredrik Y Frejd; Stefan Ståhl
Journal:  Curr Opin Biotechnol       Date:  2011-07-02       Impact factor: 9.740

3.  Engineered antibody domains with significantly increased transcytosis and half-life in macaques mediated by FcRn.

Authors:  Tianlei Ying; Yanping Wang; Yang Feng; Ponraj Prabakaran; Rui Gong; Lili Wang; Karalyne Crowder; Dimiter S Dimitrov
Journal:  MAbs       Date:  2015       Impact factor: 5.857

4.  Unfolding and refolding of the reduced constant fragment of the immunoglobulin light chain. Kinetic role of the intrachain disulfide bond.

Authors:  Y Goto; K Hamaguchi
Journal:  J Mol Biol       Date:  1982-04-25       Impact factor: 5.469

5.  Allosteric disulfide bonds.

Authors:  Bryan Schmidt; Lorraine Ho; Philip J Hogg
Journal:  Biochemistry       Date:  2006-06-20       Impact factor: 3.162

6.  A novel disulfide bond in the SH2 Domain of the C-terminal Src kinase controls catalytic activity.

Authors:  Jamie E Mills; Paul C Whitford; Jennifer Shaffer; Jose N Onuchic; Joseph A Adams; Patricia A Jennings
Journal:  J Mol Biol       Date:  2006-10-26       Impact factor: 5.469

7.  Optimized expression of full-length IgG1 antibody in a common E. coli strain.

Authors:  Conrad En Zuo Chan; Angeline Pei Chiew Lim; Annie Hoi Yi Chan; Paul A MacAry; Brendon John Hanson
Journal:  PLoS One       Date:  2010-04-20       Impact factor: 3.240

8.  Engineered human antibody constant domains with increased stability.

Authors:  Rui Gong; Bang K Vu; Yang Feng; DaRue A Prieto; Marzena A Dyba; Joseph D Walsh; Ponraj Prabakaran; Timothy D Veenstra; Sergey G Tarasov; Rieko Ishima; Dimiter S Dimitrov
Journal:  J Biol Chem       Date:  2009-03-23       Impact factor: 5.157

9.  The CCPN data model for NMR spectroscopy: development of a software pipeline.

Authors:  Wim F Vranken; Wayne Boucher; Tim J Stevens; Rasmus H Fogh; Anne Pajon; Miguel Llinas; Eldon L Ulrich; John L Markley; John Ionides; Ernest D Laue
Journal:  Proteins       Date:  2005-06-01
View more
  1 in total

1.  The reduced form of the antibody CH2 domain.

Authors:  Zhaoyong Xi; Xianglei Liu; Rui Lin; John D Persons; Tatiana V Ilina; Wei Li; Dimiter S Dimitrov; Rieko Ishima
Journal:  Protein Sci       Date:  2021-06-16       Impact factor: 6.993

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.